Logo image of UDMY

UDEMY INC (UDMY) Stock Fundamental Analysis

NASDAQ:UDMY - Nasdaq - US9026851066 - Common Stock - Currency: USD

6.01  -0.11 (-1.8%)

After market: 6.02 +0.01 (+0.17%)

Fundamental Rating

4

Taking everything into account, UDMY scores 4 out of 10 in our fundamental rating. UDMY was compared to 72 industry peers in the Diversified Consumer Services industry. UDMY scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. UDMY has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

UDMY had positive earnings in the past year.
In the past year UDMY had a positive cash flow from operations.
UDMY had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: UDMY reported negative operating cash flow in multiple years.
UDMY Yearly Net Income VS EBIT VS OCF VS FCFUDMY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

UDMY has a Return On Assets (-14.08%) which is in line with its industry peers.
The Return On Equity of UDMY (-43.21%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -14.08%
ROE -43.21%
ROIC N/A
ROA(3y)-16.47%
ROA(5y)-17.55%
ROE(3y)-39.54%
ROE(5y)-143.65%
ROIC(3y)N/A
ROIC(5y)N/A
UDMY Yearly ROA, ROE, ROICUDMY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -200 -400

1.3 Margins

The Gross Margin of UDMY (62.54%) is better than 77.78% of its industry peers.
In the last couple of years the Gross Margin of UDMY has grown nicely.
UDMY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 62.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.88%
GM growth 5Y5.41%
UDMY Yearly Profit, Operating, Gross MarginsUDMY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

6

2. Health

2.1 Basic Checks

UDMY does not have a ROIC to compare to the WACC, probably because it is not profitable.
UDMY has less shares outstanding than it did 1 year ago.
UDMY has more shares outstanding than it did 5 years ago.
There is no outstanding debt for UDMY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
UDMY Yearly Shares OutstandingUDMY Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
UDMY Yearly Total Debt VS Total AssetsUDMY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

UDMY has an Altman-Z score of 0.56. This is a bad value and indicates that UDMY is not financially healthy and even has some risk of bankruptcy.
UDMY has a Altman-Z score (0.56) which is in line with its industry peers.
UDMY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 0.56
ROIC/WACCN/A
WACC8.98%
UDMY Yearly LT Debt VS Equity VS FCFUDMY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 1.27 indicates that UDMY should not have too much problems paying its short term obligations.
UDMY's Current ratio of 1.27 is in line compared to the rest of the industry. UDMY outperforms 52.78% of its industry peers.
A Quick Ratio of 1.27 indicates that UDMY should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.27, UDMY perfoms like the industry average, outperforming 52.78% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 1.27
UDMY Yearly Current Assets VS Current LiabilitesUDMY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 2305843009213693952.00% over the past year.
The Revenue has been growing slightly by 7.92% in the past year.
The Revenue has been growing by 23.27% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)2305843009213694000%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%400%
Revenue 1Y (TTM)7.92%
Revenue growth 3Y15.11%
Revenue growth 5Y23.27%
Sales Q2Q%5.49%

3.2 Future

The Earnings Per Share is expected to grow by 50.99% on average over the next years. This is a very strong growth
Based on estimates for the next years, UDMY will show a quite strong growth in Revenue. The Revenue will grow by 10.15% on average per year.
EPS Next Y163.5%
EPS Next 2Y96.79%
EPS Next 3Y50.99%
EPS Next 5YN/A
Revenue Next Year1.76%
Revenue Next 2Y3.67%
Revenue Next 3Y6.62%
Revenue Next 5Y10.15%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
UDMY Yearly Revenue VS EstimatesUDMY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M 1B
UDMY Yearly EPS VS EstimatesUDMY Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 0.6

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 37.56 indicates a quite expensive valuation of UDMY.
Compared to the rest of the industry, the Price/Earnings ratio of UDMY is on the same level as its industry peers.
UDMY is valuated rather expensively when we compare the Price/Earnings ratio to 27.63, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 14.26, the valuation of UDMY can be described as correct.
Compared to the rest of the industry, the Price/Forward Earnings ratio of UDMY indicates a somewhat cheap valuation: UDMY is cheaper than 77.78% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 20.85. UDMY is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 37.56
Fwd PE 14.26
UDMY Price Earnings VS Forward Price EarningsUDMY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, UDMY is valued a bit cheaper than the industry average as 65.28% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 23.2
EV/EBITDA N/A
UDMY Per share dataUDMY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

UDMY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as UDMY's earnings are expected to grow with 50.99% in the coming years.
PEG (NY)0.23
PEG (5Y)N/A
EPS Next 2Y96.79%
EPS Next 3Y50.99%

0

5. Dividend

5.1 Amount

UDMY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

UDEMY INC

NASDAQ:UDMY (4/21/2025, 8:00:01 PM)

After market: 6.02 +0.01 (+0.17%)

6.01

-0.11 (-1.8%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)02-13 2025-02-13/amc
Earnings (Next)04-30 2025-04-30/amc
Inst Owners83.75%
Inst Owner Change1.76%
Ins Owners2.89%
Ins Owner Change10.01%
Market Cap887.92M
Analysts75.79
Price Target11.12 (85.02%)
Short Float %3.57%
Short Ratio4.09
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)268.05%
Min EPS beat(2)49.54%
Max EPS beat(2)486.56%
EPS beat(4)3
Avg EPS beat(4)153.2%
Min EPS beat(4)-262.44%
Max EPS beat(4)486.56%
EPS beat(8)7
Avg EPS beat(8)165.55%
EPS beat(12)11
Avg EPS beat(12)121.44%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.06%
Min Revenue beat(2)-0.56%
Max Revenue beat(2)0.69%
Revenue beat(4)1
Avg Revenue beat(4)-0.68%
Min Revenue beat(4)-1.86%
Max Revenue beat(4)0.69%
Revenue beat(8)4
Avg Revenue beat(8)0.11%
Revenue beat(12)6
Avg Revenue beat(12)-0.01%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-2.26%
EPS NQ rev (1m)0%
EPS NQ rev (3m)24.39%
EPS NY rev (1m)-2.62%
EPS NY rev (3m)11.56%
Revenue NQ rev (1m)-0.11%
Revenue NQ rev (3m)-2.15%
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)-1.58%
Valuation
Industry RankSector Rank
PE 37.56
Fwd PE 14.26
P/S 1.13
P/FCF 23.2
P/OCF 16.74
P/B 4.5
P/tB 5.89
EV/EBITDA N/A
EPS(TTM)0.16
EY2.66%
EPS(NY)0.42
Fwd EY7.01%
FCF(TTM)0.26
FCFY4.31%
OCF(TTM)0.36
OCFY5.97%
SpS5.32
BVpS1.34
TBVpS1.02
PEG (NY)0.23
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.08%
ROE -43.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 62.54%
FCFM 4.87%
ROA(3y)-16.47%
ROA(5y)-17.55%
ROE(3y)-39.54%
ROE(5y)-143.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.88%
GM growth 5Y5.41%
F-Score7
Asset Turnover1.3
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 58.12%
Cap/Sales 1.88%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.27
Quick Ratio 1.27
Altman-Z 0.56
F-Score7
WACC8.98%
ROIC/WACCN/A
Cap/Depr(3y)61.78%
Cap/Depr(5y)87.15%
Cap/Sales(3y)2.06%
Cap/Sales(5y)2.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2305843009213694000%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%400%
EPS Next Y163.5%
EPS Next 2Y96.79%
EPS Next 3Y50.99%
EPS Next 5YN/A
Revenue 1Y (TTM)7.92%
Revenue growth 3Y15.11%
Revenue growth 5Y23.27%
Sales Q2Q%5.49%
Revenue Next Year1.76%
Revenue Next 2Y3.67%
Revenue Next 3Y6.62%
Revenue Next 5Y10.15%
EBIT growth 1Y35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year551.62%
EBIT Next 3Y134.34%
EBIT Next 5Y85.56%
FCF growth 1Y353.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2745.54%
OCF growth 3YN/A
OCF growth 5YN/A